| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.14 | 0.7 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |